Fennec Pharmaceuticals Inc.

NASDAQ: FENC
Share price (8/8/25): $8.33
Market cap (8/8/25): $230 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

Prospectuses and Registrations Filter

Prospectus with selling stockholder info

Shelf registration

Prospectus supplement

Shelf registration

Shelf registration

Ownership Filter

News Filter

Shareholder Vote Results

Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

Announces Commercial Launch of Pedmarqsiò in Germany

Announces Pedmarqsiò Positive Recommendation by Nice for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales

~ $13 Million Convertible Debt Repayment From Available Cash ~ ~ Elimination of Approximately $1.5 Million in Annual Interest Expense and Potential Equity Overhang of Approximately 1.6 Million Shares ~

Proxies Filter

Definitive proxy

Definitive proxy

Definitive proxy

Definitive proxy

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC